STEVEN JOSEPH SIEGEL
Medical Practice in Berwyn, PA

License number
Pennsylvania MD065070L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Berwyn, PA 19312

Personal information

See more information about STEVEN JOSEPH SIEGEL at radaris.com
Name
Address
Phone
Steven Siegel
3518 Wood Rd, Tannersville, PA 18372
(570) 350-9765
Steven Siegel, age 52
3518 Wood Rd, Tannersville, PA 18372
Steven Siegel
712 Napoleon St, Johnstown, PA 15901
Steven M Siegel, age 78
208 Springhouse Ln, Pittsburgh, PA 15238
(412) 963-1740
(412) 963-1697
Steven M Siegel
1323 Carson St, Pittsburgh, PA 15203
(412) 381-5602

Professional information

Steven Siegel Photo 1

Drug-Containing Implants And Methods Of Use Thereof

US Patent:
8221778, Jul 17, 2012
Filed:
Jul 18, 2005
Appl. No.:
11/183232
Inventors:
Steven Siegel - Berwyn PA, US
Karen Winey - Philadelphia PA, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61F 13/00, A61F 2/10, A61B 19/00
US Classification:
424423, 424422, 424426, 424428
Abstract:
The present invention provides implants comprising a therapeutic drug and a polymer containing polylactic acid (PLA) and optionally polyglycolic acid (PGA). The present invention also provides methods of maintaining a therapeutic level of a drug in a subject, releasing a therapeutic drug at a substantially linear rate, and treating schizophrenia and other diseases and disorders, utilizing implants of the present invention.


Steven Siegel Photo 2

Drug-Containing Implants And Methods Of Use Thereof

US Patent:
2009029, Dec 3, 2009
Filed:
Jul 18, 2006
Appl. No.:
11/988137
Inventors:
Steven Siegel - Berwyn PA, US
Karen Winey - Philadelphia PA, US
International Classification:
A61F 13/00, A61K 31/519
US Classification:
424422, 51425941
Abstract:
The present invention provides implants comprising a therapeutic drug and a polymer containing polylactic acid (PLA) and optionally polyglycolic acid (PGA). The present invention also provides methods of maintaining a therapeutic level of a drug in a subject, releasing a therapeutic drug at a substantially linear rate, and treating schizophrenia and other diseases and disorders, utilizing implants of the present invention.


Steven Siegel Photo 3

Polymer-Based Surgically Implantable Haloperidol Delivery Systems And Methods For Their Production And Use

US Patent:
2010010, Apr 29, 2010
Filed:
Oct 20, 2009
Appl. No.:
12/582615
Inventors:
Steven J. SIEGEL - Berwyn PA, US
Karen I. Winey - Philadelphia PA, US
Raquel E. Gur - Philadelphia PA, US
Robert H. Lenox - Califon NJ, US
International Classification:
A61F 2/00, A61K 31/451, A61P 25/00
US Classification:
424423, 514327
Abstract:
Surgically implantable drug delivery systems for long-term delivery of haloperidol containing a biodegradable polymer and haloperidol fabricated into the surgically implantable drug delivery systems via solvent casting and compression molding are provided. Also provided are methods for producing the surgically implantable drug delivery systems and methods for using these systems in the treatment of psychotic disorders such as schizophrenia.


Steven Siegel Photo 4

Long-Term Delivery Formulations And Methods Of Use Thereof

US Patent:
2008030, Dec 11, 2008
Filed:
Jan 12, 2005
Appl. No.:
10/585611
Inventors:
Steven Siegel - Berwyn PA, US
Karen Winey - Philadelphia PA, US
Assignee:
UNIVERSITY OF PENNSYLVANIA - Philadelphia PA
International Classification:
A61F 2/04, A61K 31/519, A61K 31/451, A61K 31/551, A61K 31/497, A61K 31/554, A61K 31/496, A61K 47/30
US Classification:
424423, 51425941, 51425308, 51421113, 51425404, 5147723
Abstract:
The present invention provides a method, a kit and compositions for long-term release of a drug at a constant therapeutically effective level for nervous system disorders where adherence to therapeutic regimen is problematic. In particular, to the therapy of psychotic disorders.


Steven Siegel Photo 5

Drug-Containing Implants And Methods Of Use Thereof

US Patent:
2013006, Mar 14, 2013
Filed:
Jun 7, 2012
Appl. No.:
13/490787
Inventors:
Steven SIEGEL - Berwyn PA, US
Karen WINEY - Philadelphia PA, US
International Classification:
A61K 31/519, A61P 25/18, A61K 49/00
US Classification:
424 92, 51425941
Abstract:
The present invention provides implants comprising a therapeutic drug and a polymer containing polylactic acid (PLA) and optionally polyglycolic acid (PGA). The present invention also provides methods of maintaining a therapeutic level of a drug in a subject, releasing a therapeutic drug at a substantially linear rate, and treating schizophrenia and other diseases and disorders, utilizing implants of the present invention.


Steven Siegel Photo 6

Polymer-Based Surgically Implantable Haloperidol Delivery Systems And Methods For Their Production And Use

US Patent:
7666445, Feb 23, 2010
Filed:
Oct 19, 2001
Appl. No.:
10/046504
Inventors:
Steven J. Siegel - Berwyn PA, US
Karen I. Winey - Philadelphia PA, US
Raquel E. Gur - Philadelphia PA, US
Robert H. Lenox - Califon NJ, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61F 2/00
US Classification:
424426
Abstract:
Surgically implantable drug delivery systems for long-term delivery of haloperidol containing a biodegradable polymer and haloperidol fabricated into the surgically implantable drug delivery systems via solvent casting and compression molding are provided. Also provided are methods for producing the surgically implantable drug delivery systems and methods for using these systems in the treatment of psychotic disorders such as schizophrenia.


Steven Siegel Photo 7

Drug-Containing Implants And Methods Of Use Thereof

US Patent:
8329203, Dec 11, 2012
Filed:
Aug 3, 2005
Appl. No.:
11/195845
Inventors:
Steven Siegel - Berwyn PA, US
Karen Winey - Philadelphia PA, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61F 13/00, A61F 2/10, A61B 19/00
US Classification:
424423, 424422, 424426, 424428
Abstract:
The present invention provides implants comprising a therapeutic drug and a polymer containing polylactic acid (PLA) and optionally polyglycolic acid (PGA). The present invention also provides methods of maintaining a therapeutic level of a drug in a subject, releasing a therapeutic drug at a substantially linear rate, and treating schizophrenia and other diseases and disorders, utilizing implants of the present invention.


Steven Siegel Photo 8

Methods For Treating Parkinson's Disease

US Patent:
2011015, Jun 30, 2011
Filed:
Nov 2, 2010
Appl. No.:
12/938136
Inventors:
Terri B. Sebree - Gladwyne PA, US
Steven J. Siegel - Berwyn PA, US
International Classification:
A61K 31/4985, A61K 31/404, A61F 2/00, A61K 31/198, A61K 31/437, A61K 31/428, A61K 31/496, A61P 25/16
US Classification:
424422, 514418, 514567, 514250, 514288, 514367, 5142522
Abstract:
Methods for restoring normal patterns of activity in a subject suffering from Parkinson's Disease are disclosed that include administering an effective steady state concentration of a dopamine modulating compound continuously for a prolonged period of time such that normal patterns of activity are substantially restored in the subject.


Steven Siegel Photo 9

Implants For The Treatment Of Dopamine Associated States

US Patent:
8475829, Jul 2, 2013
Filed:
Apr 6, 2007
Appl. No.:
11/784526
Inventors:
Terri B. Sebree - Gladwyne PA, US
Steven J. Siegel - Berwyn PA, US
Assignee:
NuPathe Inc. - Conshohocken PA
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61F 2/02
US Classification:
424426, 424422, 424423, 424424, 514415
Abstract:
Biodegradable implants comprising dopamine modulating compounds are described.


Steven Siegel Photo 10

Implants For The Treatment Of Dopamine Associated States

US Patent:
8475830, Jul 2, 2013
Filed:
Feb 29, 2008
Appl. No.:
12/074101
Inventors:
Terri B. Sebree - Gladwyne PA, US
Steven J. Siegel - Berwyn PA, US
Assignee:
NuPathe Inc. - Conshohocken PA
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61F 2/02
US Classification:
424426, 424422, 424423, 424424, 514415
Abstract:
Biodegradable implants comprising dopamine modulating compounds are described.